MDV analyzer

MDV analyzer background

Web Tool Service

MDV analyzer

MDV analyzer, a web tool featuring analyses for patient count,
treatment volume, and more with a medical database

Analyses for patient count, prescription duration, treatment volume, and more based on Japan’s largest medical database are available.
In addition to diseases and medications, the database also supports multifaceted analyses based on actual medical procedures, such as surgeries and tests.

MDV analyzer
Free Trial
MDV analyzer
User Login
Contact us

EBM Medical Database

Data like DPC data, lab test data, and claim data sourced from medical institutions and insurers are processed into a database upon data anonymization. It is utilized by pharmaceutical companies, medical device companies, academia, and public research institutions for marketing research, clinical research, etc.

construction of the Medical Database for MDV analyzer

Feature Overview

All-round usage from development to regulatory submission, not to mention marketing strategy and understanding the target population for database study. Standardized analyses are included to address time consuming procedures from definition to delivery that occurs with ad-hoc service.
*Data can be disclosed to a third party upon a disclosure request.

Main Features of MDV analyzer

Analysis utilizing the hospital and health insurance databases can be performed at the same time

Aside from the comparison in market share with other companies’ formulations, demand on dosage form can also be captured for drug development. In addition, market share for hospitals and general practitioners can be captured respectively when using the health insurance database.

MDVanalyzer Sample image1

For marketing strategy materials

With features including rapid data extraction, definitions based on know-how, and visually appealing graph design, the new continued switched dropout analysis enable the creation of flexible marketing strategy materials.

MDVanalyzer Sample image2
MDVanalyzer Sample image3
MDVanalyzer Sample image4

For drugs with fluctuating treatment volume, actual situation can be checked with a histogram of treatment volume per prescription.

MDVanalyzer Sample image5

Disease-based market share can be tracked with monthly trend analysis of multi-indication drugs, including new indications.

MDVanalyzer Sample image6

Useful tool for database study, development, and regulatory interactions

Comorbidity rankings can be used to clarify the actual situation of any medication that is considered as off-label use.

MDVanalyzer Sample image7

By using the histograms of treatment volume and duration, actual usage can be ascertained if it is in line with the package insert, resulting in the facilitation in pharmacovigilance.

MDVanalyzer Sample image8
MDV analyzer
Free Trial
MDV analyzer
User Login
Contact us

Main Steps to Get Started

Demo (feature overview)

Our representative will provide an introduction to the types of analyses that can be performed using each web tool.

down arrow

Consultation

The most suitable web tool will be proposed.

down arrow

Contract

Once the tool has been decided, we will provide a draft contract accordingly

down arrow

Delivery

We will set up the necessary accounts and share the login IDs and passwords prior to the start of service.

FAQs

Before use

Currently, the web tool is not available for trial purpose. Our representative can provide an introduction to the web tool based on your specific requirements. Please feel free to contact us.
Our representative can provide an introduction on how the web tool operates in advance. Please feel free to contact us.
We have brochures for our web tool services. Please contact us if you are interested.

About the specifications

Marketing: Prescription trends, market analysis, etc.
Academia and pharmacovigilance: Exploring potential research, regulatory submission, etc.
R&D: Field research, assessing status of drugs with similar effects to those under development, etc.
Maintenance is performed once a month, and the latest data becomes available after the maintenance.
It is possible. However, prior to publication, we require a third-party disclosure agreement(TPA) with our company and a review of the materials to be published.
We receive many disclosure requests every year, and the results are used not only for regulatory submissions but also during meetings with physicians.
The data analysis uses actual values, and some features have been implemented to allow for extrapolation, enabling you to view national-level data.
Within a single organization, there is no additional cost for using multiple accounts.
Yes, it is possible through a VPN connection or similar means.
Some of the web tools are available in English, please feel free to contact our representative for more information.

About the Hospital data

Currently, we have a coverage rate of approximately 30% of the 1,786 DPC-designated hospitals nationwide (as of December 31, 2024).
We collect insurance claim data for both inpatient and outpatient visits.
They are mainly advanced treatment hospitals, so they tend to have a higher number of patients with more severe conditions compared to clinics. However, there is also a significant number of patients in primary care areas, such as those with lifestyle-related diseases, and we receive many requests for analysis.
Our data covers DPC hospitals nationwide, and the age and gender distribution of patients is similar to the survey published by the Ministry of Health, Labour and Welfare regarding the patient distribution in medical institutions across Japan. Therefore, it is considered to be representative.
Since it is the largest database in Japan with over 50 million patients, the data has been utilized in research in different fields, including intractable and rare diseases.
Update is performed at the end of every month, and the data two months prior to the update will be the latest data. (For example, the data of January 2021 will be available after the update performed at the end of March 2021)
Given the large scale of the database, we are confident that we can secure a robust number of cases for research in any disease area.
The web tool does not currently include data fields for assessing disease severity. However, through a separate service, it is possible to obtain data fields that allow for the assessment of severity in certain disease areas.
There is a function in MDV analyzer that allows one to perform extrapolation to obtain results at the national level.
Unfortunately, our database only includes medical information that is eligible for insurance reimbursement, as it is based on claim data.
Unfortunately, our database only includes medical information that is eligible for insurance reimbursement, as it is based on claim data.

About Health insurance data

It is sourced from 223 health insurance societies across Japan. (As of January 2025)
We collect insurance claim data for both inpatient and outpatient visits.
Currently, health checkup data is not available.
Although it is not possible to link the hospital data and the health insurance data, it is possible to extract data under exactly the same conditions from each database and analyze differences in trends, for example.
Since clinic data makes up 80% of the database, we are particularly strong in areas where treatment is primarily provided at clinics.
With its high traceability, patients’ record can be traced even if they transferred to another hospital without being counted as a new patient, resulting in an outstanding advantage on creating treatment flows.
We believe this is suitable for research that does not require elderly patient, or studies on treatments between clinics and hospitals.
As long as a patient is affiliated with the same health insurance association, it can be tracked.
This response needs to be update as the extrapolication function is also working for health insurance data.
Unfortunately, our database only includes medical information that is eligible for insurance reimbursement, as it is based on claim data.
MDV analyzer
Free Trial
MDV analyzer
User Login
Contact us

page top